2,048 reports of this reaction
11.4% of all BOSUTINIB reports
#1 most reported adverse reaction
DIARRHOEA is the #1 most commonly reported adverse reaction for BOSUTINIB, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 2,048 FDA adverse event reports linking BOSUTINIB to DIARRHOEA. This represents approximately 11.4% of all 17,905 adverse event reports for this drug.
Patients taking BOSUTINIB who experience diarrhoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIARRHOEA is a frequently reported adverse event for BOSUTINIB, accounting for a significant proportion of all reports.
In addition to diarrhoea, the following adverse reactions have been reported for BOSUTINIB:
The following drugs have also been linked to diarrhoea in FDA adverse event reports:
DIARRHOEA has been reported as an adverse event in 2,048 FDA reports for BOSUTINIB. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIARRHOEA accounts for approximately 11.4% of all adverse event reports for BOSUTINIB, making it one of the most commonly reported side effect.
If you experience diarrhoea while taking BOSUTINIB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.